Holdings (Uk) Llp Svf's Net Worth

$926 Million

Estimate Recalculated Feb 22, 2024 09:07PM EST

Who is Holdings (Uk) Llp Svf?

Holdings (Uk) Llp Svf has an estimated net worth of $926 Million. This is based on reported shares across multiple companies, which include Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., Urovant Sciences Ltd., Axovant Gene Therapies Ltd., and Getaround, Inc.

SEC CIK

Holdings (Uk) Llp Svf's CIK is 0001716727

Past Insider Trading and Trends

2019 was Holdings (Uk) Llp Svf's most active year for acquiring shares with 28 total transactions. Holdings (Uk) Llp Svf's most active month to acquire stocks was the month of May. 2023 was Holdings (Uk) Llp Svf's most active year for disposing of shares, totalling 2 transactions. Holdings (Uk) Llp Svf's most active month to dispose stocks was the month of February. 2018 saw Holdings (Uk) Llp Svf paying a total of $161,399,997.55 for 28,738,300 shares, this is the most they've acquired in one year. In 2023 Holdings (Uk) Llp Svf cashed out on 22,000,000 shares for a total of $222,000,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Arbutus Biopharma Corp (ABUS) Snapshot price: $2.4912

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 4
0
0
Jan 12
Form 4
0
0
Oct 16
Form 3
0
0
No matching records found

Myovant Sciences Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 4
+6.32%
2.42M
$8.25
$19,999,996.50
40.77M
Jun 4
Form 4
+2.98%
1.11M
$20.27
$22,500,004.05
38.34M
Apr 2
Form 3
0
0
No matching records found

Roivant Sciences Ltd. (ROIV) Snapshot price: $10.395

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-12.04%
-10.00M
$12.60
-$126,000,000.00
73.03M
Sep 28
Form 4
-12.63%
-12.00M
$8.00
-$96,000,000.00
83.03M
Mar 20
Form 4
-4.37%
-4.34M
$4.75
-$20,633,615.25
95.03M
Nov 10
Form 3
0
0
No matching records found

Urovant Sciences Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 4
+0.08%
18.2K
$8.32
$151,380.99
22.86M
Scheduled
Jun 17 - Jun 19
Form 4
+0.10%
22.01K
$8.06
$177,300.64
22.84M
Scheduled
Jun 12 - Jun 14
Form 4
+0.09%
21.34K
$8.31
$177,247.38
22.82M
Scheduled
Jun 7 - Jun 11
Form 4
+0.09%
21.12K
$7.86
$165,950.15
22.8M
Scheduled
Jun 4 - Jun 6
Form 4
+0.08%
17.75K
$7.83
$138,946.36
22.78M
Scheduled
May 30 - Jun 3
Form 4
+0.02%
14.48K
$7.64
$110,461.18
68.24M
Scheduled
May 24 - May 29
Form 4
+0.09%
19.83K
$8.22
$162,918.35
22.75M
Scheduled
May 21 - May 23
Form 4
+0.10%
21.61K
$7.54
$162,875.90
22.73M
May 16 - May 20
Form 4
+13.38%
2.68M
$14.00
$37,499,994.00
22.7M
Oct 1
Form 3
0
0
No matching records found

Axovant Gene Therapies Ltd. (SIOX) Snapshot price: $0.475

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 4
+6.71%
6.67M
$1.50
$10,000,000.50
105.95M
Mar 18
Form 4
+11.20%
10M
$1.00
$10,000,000.00
99.29M
Dec 18
Form 4
+19.05%
14.29M
$1.75
$24,999,999.50
89.29M
Jun 5
Form 3
0
0
No matching records found